Imipenem resistance in Enterobacter aerogenes is associated with derepression of chromosomal cephalosporinases and impaired permeability. 1992

L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
Department of Bacteriology, Hellenic Pasteur Institute, Athens University, Greece.

Enterobacter aerogenes mutants with high-level resistance to imipenem were studied. They were derived from strains characterized by stable over-production of a class-I beta-lactamase. This enzyme (pI = 8.2) exhibited high affinity toward imipenem and hydrolysed the drug slowly. Imipenem-resistant mutants lacked a major 43-kDa outer membrane protein and displayed decreased permeability to cephaloridine. Introduction of a plasmid coding for the regulatory ampD gene abolished beta-lactamase production and rendered the mutants susceptible to imipenem.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane
D002509 Cephaloridine A cephalosporin antibiotic. Cefaloridine,Cephalomycine,Cephaloridin,Ceporin
D002510 Cephalosporinase beta-Lactamase II,Cephalexin Amidase,Cephalosporin Amido-beta-Lactam Hydrolase,Cephalosporin beta-Lactamase,Amidase, Cephalexin,Amido-beta-Lactam Hydrolase, Cephalosporin,Cephalosporin Amido beta Lactam Hydrolase,Cephalosporin beta Lactamase,Hydrolase, Cephalosporin Amido-beta-Lactam,beta Lactamase II,beta-Lactamase, Cephalosporin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004754 Enterobacter Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
D015378 Imipenem Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. Imipemide,N-Formimidoylthienamycin,Imipenem Anhydrous,Imipenem, Anhydrous,MK-0787,MK0787,Anhydrous Imipenem,Anhydrous, Imipenem,MK 0787,N Formimidoylthienamycin

Related Publications

L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
March 2000, Journal of clinical microbiology,
L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
May 1995, Enfermedades infecciosas y microbiologia clinica,
L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
November 2008, The Journal of infection,
L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
May 2004, Biochemical and biophysical research communications,
L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
January 1990, The Journal of antimicrobial chemotherapy,
L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
October 1991, The Journal of antimicrobial chemotherapy,
L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
August 1993, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
February 2003, Biochemical and biophysical research communications,
L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
January 2015, PloS one,
L S Tzouvelekis, and E Tzelepi, and A F Mentis, and A C Vatopoulos, and A Tsakris
January 1991, Chemotherapy,
Copied contents to your clipboard!